Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current pharmaceutical design

Showing results (181-190 of 10,653) with videos related to

Pageof 1,066
Sort By:
Current Pharmaceutical Design|November 15, 2006
TLR2 and TLR4 expression during bacterial infectionsE Lorenz
Current Pharmaceutical Design|November 15, 2006
Recognition of fungal pathogens by toll-like receptorsMihai G Netea, Gerben Ferwerda, Chantal A A van der Graaf, et al.
Current Pharmaceutical Design|November 15, 2006
Toll-like receptor-positive cells and recognition of pathogens: how human myeloid dendritic cells respond to in vitro infection with Leishmania infantumMaria Pepe, Maria Altamura, Rosa Spinelli, et al.
Current Pharmaceutical Design|December 16, 2006
Pro-oxidant milieu blunts scissors: insight into tumor progression, drug resistance, and novel druggable targetsShazib Pervaiz
Current Pharmaceutical Design|December 16, 2006
Sensor/effector drug design with potential relevance to cancerFiona H Fry, Claus Jacob
Current Pharmaceutical Design|December 16, 2006
The heterodimeric sweet taste receptor has multiple potential ligand binding sitesMeng Cui, Peihua Jiang, Emeline Maillet, et al.
Current Pharmaceutical Design|December 16, 2006
Development of quantitative structure-activity relationships and its application in rational drug designGuang-Fu Yang, Xiaoqin Huang
Current Pharmaceutical Design|December 16, 2006
Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosisL E Schmidt, H Ring-Larsen
Current Pharmaceutical Design|December 16, 2006
The psychopharmacology of European herbs with cognition-enhancing propertiesDavid O Kennedy, Andrew B Scholey
Current Pharmaceutical Design|December 16, 2006
Polymeric micelles for drug deliveryS R Croy, G S Kwon
Pageof 1,066

Showing results (181-190 of 10,653) with videos related to

Sort By:
Pageof 1,066
Current Pharmaceutical Design|November 15, 2006
TLR2 and TLR4 expression during bacterial infectionsE Lorenz
Current Pharmaceutical Design|November 15, 2006
Recognition of fungal pathogens by toll-like receptorsMihai G Netea, Gerben Ferwerda, Chantal A A van der Graaf, et al.
Current Pharmaceutical Design|November 15, 2006
Toll-like receptor-positive cells and recognition of pathogens: how human myeloid dendritic cells respond to in vitro infection with Leishmania infantumMaria Pepe, Maria Altamura, Rosa Spinelli, et al.
Current Pharmaceutical Design|December 16, 2006
Pro-oxidant milieu blunts scissors: insight into tumor progression, drug resistance, and novel druggable targetsShazib Pervaiz
Current Pharmaceutical Design|December 16, 2006
Sensor/effector drug design with potential relevance to cancerFiona H Fry, Claus Jacob
Current Pharmaceutical Design|December 16, 2006
The heterodimeric sweet taste receptor has multiple potential ligand binding sitesMeng Cui, Peihua Jiang, Emeline Maillet, et al.
Current Pharmaceutical Design|December 16, 2006
Development of quantitative structure-activity relationships and its application in rational drug designGuang-Fu Yang, Xiaoqin Huang
Current Pharmaceutical Design|December 16, 2006
Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosisL E Schmidt, H Ring-Larsen
Current Pharmaceutical Design|December 16, 2006
The psychopharmacology of European herbs with cognition-enhancing propertiesDavid O Kennedy, Andrew B Scholey
Current Pharmaceutical Design|December 16, 2006
Polymeric micelles for drug deliveryS R Croy, G S Kwon
Pageof 1,066